ライフサイエンスコーパス: adenosine 5'-triphosphate

1 s nucleotide (2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate).

2 esponse to uridine 5'-triphosphate than with adenosine 5'-triphosphate.

3 ine 5'-triphosphate and alpha,beta-methylene adenosine 5'-triphosphate.

4 hat K501 in the KGAP sequence interacts with adenosine 5'-triphosphate.

5 lly catalyse substrate phosphorylation using adenosine 5'-triphosphate.

6 ulation of the P2X7 purinergic receptor with adenosine 5'-triphosphate.

7 escent analog 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate.

8 y on oxidative phosphorylation to synthesize adenosine 5'-triphosphate.

9 f Buk2 complexed with (beta,gamma-methylene) adenosine 5'-triphosphate.

10 or antagonist 2',3'-O-(2,4,6-Trinitrophenyl) adenosine 5'-triphosphate (100 microM) indicating P2X re

11 e 5'-triphosphate and high concentrations of adenosine 5'-triphosphate (1000-5000 microM) caused a si

12 Superfusion of 2-methylthio-adenosine-5'-triphosphate (2-M-S-ATP) over quiescent myo

13 he corresponding ATP derivative 2-methylthio-adenosine-5'-triphosphate (2MeSATP) at 3.1 A resolution.

14 e selective P2X agonist alpha,beta-methylene-adenosine 5'-triphosphate (30 microM).

15 This analog, 8-[(4-azidophenacyl)thio]adenosine 5'-triphosphate (8-APAS-ATP) contains an aryl

16 vels of mitochondrial membrane potential and adenosine-5'-triphosphate, activation of caspase 3, and

17 d indices of lung tissue metabolic function (adenosine 5-triphosphate/adenosine 5-diphosphate ratio,

18 der of ATP > 2'- and 3'-O-(4-benzoyl-benzoyl)adenosine 5'-triphosphate alpha,beta-methyleneadenosine

19 ate, AMP-PNP (2 mM) or beta, gamma-methylene-adenosine 5'-triphosphate. AMP-PCP (2 mM).

20 alues for BzATP (2',3'-O-(4- benzoylbenzoyl) adenosine 5'-triphosphate), an antagonist of the P2Y(12)

21 gs were prevented by either coinfusion of an adenosine-5'-triphosphate analog or pretransfusion incub

22 Adenosine 5'-triphosphate and adenosine receptors have b

23 tation, which was mimicked by application of adenosine 5'-triphosphate and alpha,beta-methylene adeno

24 ion were potentiated by alpha,beta-methylene adenosine 5'-triphosphate and ARL-67156, an adenosine tr

25 d P2X(2/3) antagonist 2',3'-O-trinitrophenyl-adenosine 5'-triphosphate and by the nonselective P2 ant

26 nal motion is dynein-driven and dependent on adenosine 5'-triphosphate and glucose metabolism.

27 The P2X7 receptor agonist benzoylbenzoyl-adenosine 5'-triphosphate and high concentrations of ade

28 e generation of the primary energy currency, adenosine 5'-triphosphate and its use in the synthesis o

29 sensitivity and Michaelis constants (Km) for adenosine 5'-triphosphate and substrate; however, the LA

30 Adenosine 5'-triphosphate and uridine 5'-triphosphate eq

31 In both cell types, adenosine 5'-triphosphate and uridine 5'-triphosphate in

32 o and in vivo to probe the roles of released adenosine-5'-triphosphate and adhesion in responses to (

33 nufacturers by monitoring the degradation of adenosine-5'-triphosphate and myo-inositol-1,2,3,4,5,6-h

34 rs the ability of red blood cells to release adenosine-5'-triphosphate and that impaired adenosine-5'

35 rate analog, Ap(CH2)pp (alpha,beta-methylene adenosine 5'-triphosphate), and cyclic AMP compete for t

36 , 26S proteasomes still hydrolyzed peptides, adenosine 5'-triphosphate, and ubiquitinated substrates

37 nosine-5'-triphosphate release, supplemental adenosine-5'-triphosphate, and antibodies to red blood c

38 gues TNP-ATP [2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate] and TNP-ADP.

39 2'-Deoxy-3'-anthraniloyl adenosine-5-triphosphate (ANT-dATP) coordinated to Tb3+

40 2-propylthio-D-beta gamma-dichloromethylene adenosine 5'-triphosphate (AR-C67085), a P2Y12 receptor-

41 6-N,N-diethyl-beta-gamma-dibromomethylene-D-adenosine 5-triphosphate (ARL 67156), reduced the [Ca(2+

42 6-N,N-diethyl-beta,gamma-dibromomethylene-D-adenosine-5'-triphosphate (ARL67156) inhibition of nucle

43 6-N,N-diethyl-beta-gamma-dibromomethylene-D-adenosine-5'-triphosphate (ARL67156).

44 Adenosine 5' triphosphate (ATP) is a universal intracell

45 Extracellular adenosine 5' triphosphate (ATP) is a widespread cell-to-

46 tor fructose-6-phosphate (F6P) and substrate adenosine 5'-triphosphate (ATP) (in the presence and abs

47 Adenosine 5'-triphosphate (ATP) affects multiple intra-

48 We investigated the effects of adenosine 5'-triphosphate (ATP) alone and in combination

49 The active sites of RFC are fully bound to adenosine 5'-triphosphate (ATP) analogs, which is expect

50 Adenosine conformations of adenosine 5'-triphosphate (ATP) and adenosine 5'-diphosp

51 Adenosine conformations of adenosine 5'-triphosphate (ATP) and adenosine 5'-monopho

52 he compounds are competitive with respect to adenosine 5'-triphosphate (ATP) and bind in the kinase A

53 D required Mg2+ or Mn2+ and preactivation by adenosine 5'-triphosphate (ATP) and was inhibited by kno

54 Adenosine 5'-triphosphate (ATP) and/or related nucleotid

55 hatase (ATPase) domain residues required for adenosine 5'-triphosphate (ATP) binding and membrane att

56 and a dwell angle about 40 degrees after the adenosine 5'-triphosphate (ATP) binding dwell.

57 the back hydrophobic pocket adjacent to the adenosine 5'-triphosphate (ATP) binding site.

58 smaller using SPR detection compared to the adenosine 5'-triphosphate (ATP) bioluminescence assay in

59 Exogenous adenosine 5'-triphosphate (ATP) boosts these signaling p

60 o adenine, adenosine monophosphate, and then adenosine 5'-triphosphate (ATP) by 5'-methylthio-adenosi

61 mational change coupled to the hydrolysis of adenosine 5'-triphosphate (ATP) by a mechanism that rema

62 mitochondrial adenosine 5'-diphosphate (ADP)/adenosine 5'-triphosphate (ATP) carrier imports ADP into

63 The adenosine 5'-triphosphate (ATP) competitive cyclin-depen

64 No major changes in membrane potential or adenosine 5'-triphosphate (ATP) concentration result fro

65 While, at low adenosine 5'-triphosphate (ATP) concentrations, motors d

66 ent conclusive evidence that the presence of adenosine 5'-triphosphate (ATP) facilitates non-equilibr

67 In contrast to UDP, activation by UTP or adenosine 5'-triphosphate (ATP) greatly increased Ca(m),

68 Adenosine 5'-triphosphate (ATP) has long been considered

69 Activation of a purinergic P2 receptor by adenosine 5'-triphosphate (ATP) has previously been show

70 r the basis of stimulation of P-glycoprotein adenosine 5'-triphosphate (ATP) hydrolysis by multiple s

71 Adenosine 5'-triphosphate (ATP) hydrolysis rate was quan

72 P-binding cassette (ABC) transporters couple adenosine 5'-triphosphate (ATP) hydrolysis to substrate

73 h an unfolded protein) increased proteasomal adenosine 5'-triphosphate (ATP) hydrolysis, the step whi

74 w that CtIP also dramatically stimulates the adenosine 5'-triphosphate (ATP) hydrolysis-driven motor

75 mbient conditions using chemical energy from adenosine 5'-triphosphate (ATP) hydrolysis.

76 The role of adenosine 5'-triphosphate (ATP) in the activation mechan

77 tection of inorganic phosphate released from adenosine 5'-triphosphate (ATP) in the glutamine synthet

78 only a slight effect, while the addition of adenosine 5'-triphosphate (ATP) increased the amplitude

79 level of delivery is largely temperature and adenosine 5'-triphosphate (ATP) independent, and the mem

80 Adenosine 5'-triphosphate (ATP) is a functional molecule

81 Extracellular adenosine 5'-triphosphate (ATP) is an essential signalin

82 Adenosine 5'-triphosphate (ATP) is the currency of energ

83 We report that adenosine 5'-triphosphate (ATP) is the key neurotransmit

84 in a steady-state model to predict cellular adenosine 5'-triphosphate (ATP) levels, which also depen

85 Adenosine 5'-triphosphate (ATP) may regulate neurotransm

86 This study examined whether adenosine 5'-triphosphate (ATP) modulated inhibitory gly

87 forward to backward steps and the number of adenosine 5'-triphosphate (ATP) molecules hydrolyzed per

88 The effects of extracellular adenosine 5'-triphosphate (ATP) on pulmonary vagal affer

89 A (KDL) can tune the selectivity of MsbA for adenosine 5'-triphosphate (ATP) over ADP.

90 Adenosine 5'-triphosphate (ATP) per gram tissue decrease

91 Adenosine 5'-triphosphate (ATP) plays an essential role

92 Recent work has shown that adenosine 5'-triphosphate (ATP) plays an important role

93 lar 2'-deoxyadenosine 5'-triphosphate (dATP)/adenosine 5'-triphosphate (ATP) ratio.

94 We have investigated adenosine 5'-triphosphate (ATP) release from SaOS-2 oste

95 one-related small molecules, with comparable adenosine 5'-triphosphate (ATP) rescue activity to idebe

96 y diverse set of inhibitors that bind to the adenosine 5'-triphosphate (ATP) site of type II topoisom

97 Based on evidence that extracellular adenosine 5'-triphosphate (ATP) stimulates glucose relea

98 on cryo-microscopy structure of the F(1)F(o)-adenosine 5'-triphosphate (ATP) synthase from A. baumann

99 Mitochondrial adenosine 5'-triphosphate (ATP) synthase is a multiprote

100 activity of the electron transport chain and adenosine 5'-triphosphate (ATP) synthase with RNA interf

101 -energy phosphate content and limitations in adenosine 5'-triphosphate (ATP) synthesis rate occur dur

102 Here, we show an efficient manner to build adenosine 5'-triphosphate (ATP) synthesizing hybrid mult

103 Addition of adenosine 5'-triphosphate (ATP) to a solution of the ani

104 al NE cells protect the airways by releasing adenosine 5'-triphosphate (ATP) to activate purinorecept

105 of this study was to test the equivalency of adenosine 5'-triphosphate (ATP) to adenosine in their ab

106 protein kinase fold transfer phosphate from adenosine 5'-triphosphate (ATP) to substrates in a proce

107 Methanocarba-adenosine 5'-triphosphate (ATP) was fixed in either a No

108 s l-Ser substrate; competitive inhibition vs adenosine 5'-triphosphate (ATP)).

109 eotide phosphate (NADPH)), energy coenzymes (adenosine 5'-triphosphate (ATP), adenosine 5'-diphosphat

110 f nucleobase/nucleotide (adenine, adenosine, adenosine 5'-triphosphate (ATP), adenosine 5'-monophosph

111 se preparation is competitively inhibited by adenosine 5'-triphosphate (ATP), an observation that ind

112 (dTMP-PCP), thymidine 5'-diphosphate (dTDP), adenosine 5'-triphosphate (ATP), and adenosine 5'-O-(3-t

113 posed of stabilized microtubules, depletant, adenosine 5'-triphosphate (ATP), and clusters of kinesin

114 diated by a purine neurotransmitter, such as adenosine 5'-triphosphate (ATP), binding to P2Y1 recepto

115 Adenosine, but not adenosine 5'-triphosphate (ATP), dose-dependently and re

116 Cellular purines, particularly adenosine 5'-triphosphate (ATP), fuel many metabolic rea

117 glycolysis is an inefficient way to generate adenosine 5'-triphosphate (ATP), however, and the advant

118 nase (PPDK) catalyzes the interconversion of adenosine 5'-triphosphate (ATP), orthophosphate (P(i)),

119 Lee et al. describe novel effects of adenosine 5'-triphosphate (ATP), which is secreted by ke

120 AP23464, a potent adenosine 5'-triphosphate (ATP)-based inhibitor of Src a

121 Recognizing the association of adenosine 5'-triphosphate (ATP)-binding cassette (ABC) t

122 ance regulator (CFTR) is a membrane-spanning adenosine 5'-triphosphate (ATP)-binding cassette (ABC) t

123 a membrane protein complex, the heteromeric adenosine 5'-triphosphate (ATP)-binding cassette transpo

124 loit currently noncatalytic cysteines in the adenosine 5'-triphosphate (ATP)-binding site via electro

125 e found to maximize occupancy of the active, adenosine 5'-triphosphate (ATP)-bound mtHsp70 at the cha

126 esults in either the high-DNA affinity form (Adenosine 5'-triphosphate (ATP)-bound) or the more inact

127 While many different classes of adenosine 5'-triphosphate (ATP)-competitive inhibitors h

128 AK), a primary enzyme in cell metabolism and adenosine 5'-triphosphate (ATP)-consuming processes, pla

129 surement of inorganic pyrophosphate (PPi) in adenosine 5'-triphosphate (ATP)-contaminated samples.

130 Adenosine 5'-triphosphate (ATP)-dependent chromatin remo

131 The adenosine 5'-triphosphate (ATP)-dependent chromatin remo

132 hether it is possible to transform a natural adenosine 5'-triphosphate (ATP)-dependent enzyme into a

133 ression of synaptic strength results from an adenosine 5'-triphosphate (ATP)-derived and A1 adenosine

134 P2X receptors (P2XRs) are adenosine 5'-triphosphate (ATP)-gated ion channels compr

135 owing peripheral nerve injury, extracellular adenosine 5'-triphosphate (ATP)-mediated purinergic sign

136 rected mutagenesis supports a model in which adenosine 5'-triphosphate (ATP)-powered movements of the

137 bit the DnaK-mediated phosphate release from adenosine 5'-triphosphate (ATP).

138 lar cargo transport, for which it hydrolyzes adenosine 5'-triphosphate (ATP).

139 nd-gated ion channels gated by extracellular adenosine 5'-triphosphate (ATP).

140 enhanced their activity after application of adenosine 5'-triphosphate (ATP, 1 mM) or alpha,beta-meth

141 Adenosine 5'-triphosphate (ATP, 30 microM) activated the

142 rker DNA and a low molecular weight analyte, adenosine 5'triphosphate (ATP), respectively.

143 th timing and force) and immediately measure adenosine 5(')-triphosphate (ATP) release and calcium mo

144 atalyzing process is that PKA can hydrolysis adenosine-5'-triphosphate (ATP) and ALP can hydrolysis p

145 in situ multiple fluorescence monitoring of adenosine-5'-triphosphate (ATP) and guanosine-5'-triphos

146 xocytosis of LBs, following stimulation with adenosine-5'-triphosphate (ATP) and phorbol 12-myristate

147 of phosphate containing metabolites such as adenosine-5'-triphosphate (ATP) and pyrophosphate (PPi).

148 Phosphate-containing metabolites such as adenosine-5'-triphosphate (ATP) and pyrophosphate play a

149 he insertion of aptamer sequences (e.g., the adenosine-5'-triphosphate (ATP) aptamer) or ion-binding

150 Here we utilize adenosine-5'-triphosphate (ATP) as a trigger for the con

151 e diatom, Skeletonema costatum, in utilizing adenosine-5'-triphosphate (ATP) based on incubation expe

152 The majority of biosensors for adenosine-5'-triphosphate (ATP) determination are based

153 Two selective chemosensors for adenosine-5'-triphosphate (ATP) determination featuring

154 The mechanically induced release of adenosine-5'-triphosphate (ATP) from osteoblastic cells

155 Extracellular Adenosine-5'-triphosphate (ATP) is an important multi-fu

156 We have shown that red blood cell (RBC) adenosine-5'-triphosphate (ATP) is better maintained and

157 Adenosine-5'-triphosphate (ATP) is generally regarded as

158 Extracellular Adenosine-5'-Triphosphate (ATP) is known to accumulate i

159 ytes can be termed as energy inefficient for adenosine-5'-triphosphate (ATP) production but energy ef

160 leading to reductions in lactate production, adenosine-5'-triphosphate (ATP) production, and reduced

161 stimulation induces the release of cellular adenosine-5'-triphosphate (ATP) that regulates T-cell ac

162 were found to selectively adsorb adenine and adenosine-5'-triphosphate (ATP), as compared to other nu

163 Adenosine-5'-triphosphate (ATP), the primary energy curr

164 that associates with the MTase and catalyses Adenosine-5'-triphosphate (ATP)-dependent DNA translocat

165 P2X receptors are trimeric adenosine-5'-triphosphate (ATP)-gated cation channels in

166 substrate complexes allowed the detection of adenosine-5'-triphosphate (ATP, detection limit 10 muM).

167 Extracellular triphosphate nucleotides (adenosine 5'-triphosphate [ATP], uridine 5'-triphosphate

168 n addition to previously published assays of adenosine 5'-triphosphate binding and hydrolysis, measur

169 nd type II and III inhibitors at or near the adenosine 5'-triphosphate binding sites are well defined

170 ABCC6, a member of the adenosine 5'-triphosphate-binding cassette family of gen

171 scular mimicry and concomitantly express the adenosine 5'-triphosphate-binding cassette transporter b

172 btained by targeting the front pocket of the adenosine 5'-triphosphate-binding site.

173 osine kinase domain of EGFR that bind to its adenosine-5' triphosphate-binding site.

174 nd the acceptor (2'(or 3')-O-(trinitrophenyl)adenosine 5'-triphosphate) binds reversibly to the activ

175 quencher for boron dipyrromethene-conjugated adenosine 5'-triphosphate (BODIPY-ATP) that is highly fl

176 the P2X(7) receptor agonist, (benzoylbenzoyl)adenosine 5' triphosphate (BzATP) or the alpha(1D)-AR ag

177 h the P2X7 receptor agonist, (benzoylbenzoyl)adenosine 5' triphosphate (BzATP), cholinergic agonist c

178 riphosphate) and 2',3'-O-(4-benzoyl-benzoyl) adenosine 5'-triphosphate (BzATP), but not by adenosine.

179 R activation with 2'(3')-O-(4-Benzoylbenzoyl)adenosine 5'-triphosphate (BzATP).

180 elective agonist, 2'-3'-O-(4-benzoylbenzoyl)-adenosine 5'-triphosphate (BzATP: 100 microM), triggers

181 receptor agonist 2'3'-O-(4-benzoyl-benzoyl)-adenosine 5'-triphosphate (BzATP; 10 microM) caused a ra

182 y addition of 2'- and 3'-O-(4-benzoylbenzoyl)adenosine 5'-triphosphate (BzATP; 30 microm) resulted in

183 de (LPS)-primed and 2'(3')-O-(benzoylbenzoyl)adenosine-5'-triphosphate (BzATP)-induced IL-1B release

184 of ATP or 2'- (or-3'-) O-(4-benzoylbenzoyl) adenosine 5'-triphosphate (BzBzATP) activated an inward

185 oquinolin-7,9-dione (1) was identified as an adenosine 5'-triphosphate competitive inhibitor of lck b

186 tazone decreased oxidative stress, increased adenosine 5'-triphosphate concentration, and exerted neu

187 % flow, no changes in function were seen and adenosine 5'-triphosphate concentrations decreased durin

188 t regulate mitochondrial membrane potential, adenosine 5'-triphosphate contents, and reactive oxygen

189 Adenosine 5'-triphosphate contributes to mechanosensory

190 The naturally occurring nucleotide 2-deoxy-adenosine 5'-triphosphate (dATP) can be used by cardiac

191 with controls reflecting higher than normal adenosine 5'-triphosphate degradation in the malignant h

192 Uptake was adenosine 5'-triphosphate-dependent and linear over a 12

193 assess the roles of the RSC, ISW1, and CHD1 adenosine 5'-triphosphate-dependent chromatin remodelers

194 work, we report the structural mechanism for adenosine 5'-triphosphate-dependent chromatin remodeling

195 Adenosine 5'-triphosphate-dependent closure of the Prp28

196 mark them for destruction by a multisubunit, adenosine 5'-triphosphate-dependent protease called the

197 The 26S proteasome is a large intracellular adenosine 5'-triphosphate-dependent protease that identi

198 (CTE) of simian retrovirus was identified as adenosine 5'-triphosphate-dependent RNA helicase A.

199 We also discuss evidence suggesting that adenosine-5'-triphosphate-dependent chromatin-remodeling

200 alpha,beta-Methylene adenosine 5'-triphosphate did not cause an increase in e

201 Using an adenosine 5'-triphosphate disodium salt (ATP) binding ap

202 n, phospholamban (PLN) is an inhibitor of an adenosine-5'-triphosphate-driven calcium pump, the Ca2+-

203 We show that an adenosine-5'-triphosphate-driven group II chaperonin, wh

204 iphosphate), and 2',3'-O-(4-benzoyl-benzoyl) adenosine 5'-triphosphate each induced cAMP accumulation

205 s were observed in a subpopulation of cells; adenosine 5'-triphosphate failed to elevate Cai in some

206 In addition, 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate fluorescence titration of BVR

207 of the adenylation of 4-chlorobenzoate with adenosine 5'-triphosphate followed by acyl transfer from

208 pends in part on the release of antiadhesive adenosine-5'-triphosphate from red blood cells, and stor

209 ping mechanism, likely arising from just one adenosine 5'-triphosphate hydrolysis event being require

210 ctive site for phosphate (P(i)) generated by adenosine 5'-triphosphate hydrolysis.

211 e in P-loop-containing enzymes that catalyze adenosine 5'-triphosphate hydrolysis.

212 prokaryotic model Hsp70 DnaK throughout its adenosine-5'-triphosphate hydrolysis (ATPase) cycle usin

213 ke the bacterial flagellar motor (BFM), ATP (adenosine-5'-triphosphate) hydrolysis probably drives bo

214 The hydrolysis of adenosine 5'-triphosphate in solutions containing magnes

215 ion of P2X(7) receptors with (benzoylbenzoyl)adenosine 5'-triphosphate increased [Ca(2+)](i), peroxid

216 tubules in a guanylnucleotide-dependent but Adenosine 5'-triphosphate-independent way.

217 al preparation was used to elucidate whether adenosine 5'-triphosphate is released from the mucosa in

218 lay reduced TKI sensitivity due to decreased adenosine 5'-triphosphate K(m).

219 ed intracellular levels of G6P, lactate, and adenosine-5'-triphosphate, leading to improved functiona

220 Adenosine-5'-triphosphate levels and red cell recovery w

221 se reaction mixture generated from magnesium adenosine 5-triphosphate (MgATP) and 4-CBA in the absenc

222 P2X7 receptor antagonist, periodate oxidized adenosine 5'-triphosphate (o-ATP), substantially inhibit

223 Adenosine 5'-triphosphate or ATP is the primary energy s

224 Carbachol, 3'-O-(4-benzoyl)benzoyl adenosine 5'-triphosphate (P2X(7) receptor agonist), AG1

225 Adenosine 5'-triphosphate plays a role in peripheral sen

226 ned and showed the inhibitor residing in the adenosine 5'-triphosphate pocket of the enzyme.

227 rescence enhancement, we discovered a robust adenosine 5'-triphosphate-powered dsRNA translocation ac

228 NRF2 activity, which enhances mitochondrial adenosine 5'-triphosphate production and cellular resist

229 pathologies and point to improving neuronal adenosine 5'-triphosphate production kinetics as a promi

230 y increasing PGK1 expression boosts neuronal adenosine 5'-triphosphate production kinetics that is su

231 Calcium stimulates mitochondrial adenosine 5'-triphosphate production, but can also initi

232 ectum led to pressure-dependent increases in adenosine 5'-triphosphate release from colorectal epithe

233 ood cells, and storage-induced deficiency in adenosine-5'-triphosphate release from transfused red bl

234 on of fresh red blood cells treated with the adenosine-5'-triphosphate release inhibitors glibenclami

235 Inhibiting adenosine-5'-triphosphate release promoted the adhesion

236 adenosine-5'-triphosphate and that impaired adenosine-5'-triphosphate release was injurious in vivo,

237 Manipulation of adenosine-5'-triphosphate release, supplemental adenosin

238 transducer that, upon binding galactose and adenosine 5'-triphosphate, relieves Gal80p repression.

239 Adenosine, after ectoenzymatic breakdown of adenosine 5'-triphosphate, seems to be involved in the l

240 Finally, mitochondrial adenosine 5'-triphosphate-sensitive K+ channels open, an

241 A structurally novel series of adenosine 5'-triphosphate-sensitive potassium (K(ATP)) c

242 y, which led to the discovery of a drug-like adenosine 5'-triphosphate-site PI3K/mTOR kinase inhibito

243 articularly affected by alpha,beta-methylene adenosine 5'-triphosphate, suggesting a correlation betw

244 ation with the first enzyme in this pathway, adenosine-5'-triphosphate sulfurylase, conferred signifi

245 The interplay between adenosine 5'-triphosphate supply and demand, dictated by

246 y released to drive proton translocation and adenosine 5'-triphosphate synthesis.

247 lysis rate of 2', 3'-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate (TNP-ATP) by F1-ATPase require

248 O-(2,4,6-trinitrophenylcyclo-hexadienylidene)adenosine 5'-triphosphate (TNP-ATP) to maltose-binding f

249 eotide analog 2',3'-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP), which acts as a flu

250 eotide analog 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate (TNP-ATP).

251 ith AF-353 or 2',3'-O-(2,4,6-Trinitrophenyl)-adenosine-5'-triphosphate (TNP-ATP), structurally distin

252 or antagonist 2',3'-O-(2,4,6-Trinitrophenyl) adenosine 5'-triphosphate, TNP-ATP (100 microM).

253 es the conversion of glucose 1-phosphate and adenosine 5'-triphosphate to ADP-glucose and pyrophospha

254 ted with beta2, cytidine 5'-diphosphate, and adenosine 5'-triphosphate to generate a NH(2)Y(730)(*) i

255 talyzes the transfer of gamma-phosphate from adenosine 5(')-triphosphate to the threonine residue of

256 ropic receptor agonist, alpha,beta-methylene adenosine 5'-triphosphate, to distinguish the ADP-induce

257 ogue TNP-ATP [2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate] to investigate the two ATP-bi

258 ATP(o) and 2'- and 3'-O-(4-benzoylbenzoyl)adenosine 5'-triphosphate triethylammonium salt (Bz-ATP)

259 of sarcoplasmic reticulum Ca-release-induced adenosine 5'-triphosphate turnover as a potential minima

260 Paradoxically, it inhibits adenosine 5'-triphosphate turnover in the absence of act

261 In HaCaT cells, adenosine 5'-triphosphate, uridine 5'-triphosphate, and

262 able ATP analog, ADPCP (beta,gamma-methylene adenosine 5'-triphosphate), was able to support apoptoso

263 MantATP [2'(3')-O-(-N-methylanthraniloyl)-adenosine 5'-triphosphate] was employed as a fluorescenc